Published in J Virol on August 01, 1993
The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol (2003) 3.71
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol (1999) 2.32
Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol (2001) 2.13
Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol (1999) 1.86
Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J Virol (2003) 1.79
Analysis of a recombinant mouse hepatitis virus expressing a foreign gene reveals a novel aspect of coronavirus transcription. J Virol (1997) 1.77
Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J Virol (1996) 1.74
Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog (2014) 1.69
Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol (2006) 1.59
Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion. J Virol (2004) 1.58
Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses (2012) 1.55
Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol (2008) 1.54
Episodic evolution mediates interspecies transfer of a murine coronavirus. J Virol (1997) 1.44
Inhibition of the alpha/beta interferon response by mouse hepatitis virus at multiple levels. J Virol (2007) 1.41
Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe (2012) 1.39
A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J Virol (1997) 1.30
The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J Virol (2003) 1.26
Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol (1998) 1.24
Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity. Proc Natl Acad Sci U S A (2013) 1.20
The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range. J Virol (1997) 1.19
Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence. Viruses (2012) 1.18
Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein. J Virol (2005) 1.16
Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor. J Virol (1995) 1.14
The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity. J Virol (1997) 1.14
The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes. J Virol (1998) 1.12
Cell-type-specific activation of the oligoadenylate synthetase-RNase L pathway by a murine coronavirus. J Virol (2013) 1.08
Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J Virol (2011) 1.07
Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J Virol (2009) 1.06
Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS One (2009) 1.05
Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrob Agents Chemother (2014) 1.04
Acute and persistent infection of human neural cell lines by human coronavirus OC43. J Virol (1999) 1.02
Intracellular complexes of viral spike and cellular receptor accumulate during cytopathic murine coronavirus infections. J Virol (1998) 0.98
Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J Virol (1999) 0.97
Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. J Virol (2005) 0.97
The N-terminal region of the murine coronavirus spike glycoprotein is associated with the extended host range of viruses from persistently infected murine cells. J Virol (2004) 0.96
Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J Virol (2005) 0.95
Murine AKAP7 has a 2',5'-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene. MBio (2014) 0.92
The murine coronavirus nucleocapsid gene is a determinant of virulence. J Virol (2009) 0.88
TNF receptor 1 mediates dendritic cell maturation and CD8 T cell response through two distinct mechanisms. J Immunol (2011) 0.87
Identification and characterization of a proteolytically primed form of the murine coronavirus spike proteins after fusion with the target cell. J Virol (2014) 0.86
Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence. J Virol (2005) 0.85
Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation. MBio (2016) 0.85
The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WU. J Virol (2015) 0.83
Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon. J Virol (2016) 0.82
Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice. PLoS One (2013) 0.82
Lineage A Betacoronavirus NS2 Proteins and the Homologous Torovirus Berne pp1a Carboxy-Terminal Domain Are Phosphodiesterases That Antagonize Activation of RNase L. J Virol (2017) 0.75
Coronaviruses induce entry-independent, continuous macropinocytosis. MBio (2014) 0.75
Antagonism of RNase L Is Required for Murine Coronavirus Replication in Kupffer Cells and Liver Sinusoidal Endothelial Cells but Not in Hepatocytes. J Virol (2016) 0.75
Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion. J Virol (2017) 0.75
Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice. Arch Virol (2015) 0.75
Coronaviruses: structure and genome expression. J Gen Virol (1988) 4.77
Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.41
Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature (1984) 3.15
The molecular biology of coronaviruses. Adv Virus Res (1983) 3.14
Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus. J Virol (1988) 2.66
Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J Virol (1987) 2.49
Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion. J Virol (1985) 2.34
Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J Virol (1990) 2.21
Protein localization and virus assembly at intracellular membranes. Curr Top Microbiol Immunol (1991) 2.18
Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J Virol (1991) 2.16
Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology (1987) 2.16
Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol (1987) 2.07
Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein that block processing to gp85 and gp37. J Virol (1987) 2.07
Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J Virol (1992) 1.91
Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology (1989) 1.79
Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J Virol (1990) 1.55
Isolation and genetic characterization of temperature-sensitive mutants of simian rotavirus SA11. Virology (1982) 1.43
Proteolytic cleavage of the murine coronavirus surface glycoprotein is not required for fusion activity. J Gen Virol (1993) 1.22
Molecular cloning and expression of a spike protein of neurovirulent murine coronavirus JHMV variant cl-2. J Gen Virol (1992) 1.22
Fusion formation by the uncleaved spike protein of murine coronavirus JHMV variant cl-2. J Virol (1993) 1.22
Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb Pathog (1987) 1.11
Localization of extensive deletions in the structural genes of two neurotropic variants of murine coronavirus JHM. Virology (1991) 1.05
Evolution of a coronavirus during persistent infection in vitro. Adv Exp Med Biol (1981) 1.00
Mouse hepatitis virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb Pathog (1992) 0.99
Characterization of a small plaque mutant of the A59 strain of mouse hepatitis virus defective in cell fusion. Adv Exp Med Biol (1987) 0.90
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med (1995) 10.99
The size and genetic composition of virus-specific RNAs in the cytoplasm of cells producing avian sarcoma-leukosis viruses. Cell (1977) 5.23
The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res (1990) 2.71
Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology (1989) 2.69
Polyadenylate sequences on Newcastle disease virus mRNA synthesized in vivo and in vitro. J Virol (1974) 2.08
The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day. Am J Cardiol (1997) 1.98
Cell-free translation of avian sarcoma virus RNA: suppression of the gag termination codon does not augment synthesis of the joint gag/pol product. Cell (1978) 1.90
Origin and function of avian retrovirus transforming genes. Cold Spring Harb Symp Quant Biol (1980) 1.89
Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence. J Virol (1999) 1.86
Mouse hepatitis virus strain A59 RNA polymerase gene ORF 1a: heterogeneity among MHV strains. Virology (1994) 1.73
Characterization of a second cleavage site and demonstration of activity in trans by the papain-like proteinase of the murine coronavirus mouse hepatitis virus strain A59. J Virol (1997) 1.71
Mouse hepatitis virus gene 5b protein is a new virion envelope protein. Virology (1994) 1.70
Cell-free translation of murine coronavirus RNA. J Virol (1982) 1.68
Intracellular processing of the N-terminal ORF 1a proteins of the coronavirus MHV-A59 requires multiple proteolytic events. Virology (1992) 1.67
Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group. J Clin Endocrinol Metab (2000) 1.58
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care (1998) 1.58
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol (1998) 1.56
Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol (2000) 1.55
At least 104 nucleotides are transposed from the 5' terminus of the avian sarcoma virus genome to the 5' termini of smaller viral mRNAs. Cell (1978) 1.53
Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein. Virology (1998) 1.48
The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J Virol (1997) 1.48
Altered pathogenesis of a mutant of the murine coronavirus MHV-A59 is associated with a Q159L amino acid substitution in the spike protein. Virology (1997) 1.46
MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology (1994) 1.45
Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis. J Virol (2001) 1.43
Identification and characterization of a 65-kDa protein processed from the gene 1 polyprotein of the murine coronavirus MHV-A59. Virology (1995) 1.39
Characterization of the leader papain-like proteinase of MHV-A59: identification of a new in vitro cleavage site. Virology (1995) 1.38
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38
Limbic encephalitis after inhalation of a murine coronavirus. Lab Invest (1988) 1.31
Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes. Science (1986) 1.31
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun (1986) 1.30
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Identification of the murine coronavirus p28 cleavage site. J Virol (1995) 1.27
Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism. J Virol (1998) 1.24
Amino acid substitutions within the leucine zipper domain of the murine coronavirus spike protein cause defects in oligomerization and the ability to induce cell-to-cell fusion. J Virol (1999) 1.19
Identification of polypeptides encoded in open reading frame 1b of the putative polymerase gene of the murine coronavirus mouse hepatitis virus A59. J Virol (1991) 1.19
Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis. Exp Mol Pathol (2001) 1.15
Detection of a murine coronavirus nonstructural protein encoded in a downstream open reading frame. Virology (1988) 1.14
In vitro synthesis of two polypeptides from a nonstructural gene of coronavirus mouse hepatitis virus strain A59. Virology (1987) 1.13
The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci (1986) 1.12
The spike protein of murine coronavirus mouse hepatitis virus strain A59 is not cleaved in primary glial cells and primary hepatocytes. J Virol (1998) 1.12
Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb Pathog (1987) 1.11
Neither B cells nor T cells are required for CNS demyelination in mice persistently infected with MHV-A59. J Neurovirol (2002) 1.10
Isolation of cilia from porcine tracheal epithelium and extraction of dynein arms. Cell Motil Cytoskeleton (1986) 1.10
Murine hepatitis virus--a model for virus-induced CNS demyelination. J Neurovirol (2002) 1.09
Expression of murine coronavirus recombinant papain-like proteinase: efficient cleavage is dependent on the lengths of both the substrate and the proteinase polypeptides. J Virol (1999) 1.08
Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression. Biol Psychiatry (1998) 1.07
Chronic subdural hematoma in the elderly: a curable lesion. J Am Geriatr Soc (1968) 1.07
Efficient autoproteolytic processing of the MHV-A59 3C-like proteinase from the flanking hydrophobic domains requires membranes. Virology (1997) 1.07
Chronic subdural hematoma in the elderly: a challenge in diagnosis and treatment. J Am Geriatr Soc (1972) 1.06
Comparative electrophoresis of the 18-22S RNAs of Newcastle disease virus. J Virol (1976) 1.04
Characterization of murine coronavirus RNA by hybridization with virus-specific cDNA probes. J Gen Virol (1983) 1.04
Antibody is required for clearance of infectious murine hepatitis virus A59 from the central nervous system, but not the liver. J Immunol (2001) 1.04
Localization of mouse hepatitis virus open reading frame 1A derived proteins. J Neurovirol (1998) 1.03
Syncytia formation induced by coronavirus infection is associated with fragmentation and rearrangement of the Golgi apparatus. Virology (1996) 1.03
Protease production by Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Infect Immun (1983) 1.01
Determinants of coronavirus MHV pathogenesis are localized to 3' portions of the genome as determined by ribonucleic acid-ribonucleic acid recombination. Lab Invest (1990) 1.01
CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res (1986) 1.00
Mouse hepatitis virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb Pathog (1992) 0.99
Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis. J Neurovirol (2001) 0.99
Effect of cordycepin (3'-deoxyadenosine) on virus-specific RNA species synthesized in Newcastle disease virus-infected cells. J Virol (1975) 0.97
Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence. J Neurovirol (2001) 0.95
Twenty-two cases of hydrocephalus treated with a silastic ventriculoperitoneal shunt. Int Surg (1969) 0.94
Amygdala-kindled seizures increase the expression of corticotropin-releasing factor (CRF) and CRF-binding protein in GABAergic interneurons of the dentate hilus. Brain Res (1997) 0.94
Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. Characterization of the H-2-inducing soluble factor elaborated by infected brain cells. J Immunol (1988) 0.93
Rat nurr1 is prominently expressed in perirhinal cortex, and differentially induced in the hippocampal dentate gyrus by electroconvulsive vs. kindled seizures. Brain Res Mol Brain Res (1997) 0.92
Non-neoplastic intrasellar cysts. Int Surg (1969) 0.92
Psychological and behavioral characteristics of normal-weight bulimics and normal-weight controls. Psychosom Med (1983) 0.92
Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8+ T cells. Microb Pathog (1995) 0.92
Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy. Epilepsia (2000) 0.91
Relationship of mood alterations to bingeing behaviour in bulimia. Br J Psychiatry (1986) 0.91
Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. J Neuroimmunol (1988) 0.90
Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa. Am J Psychiatry (1984) 0.90
Glucocorticoid treatment increases the ability of CRH to induce seizures. Neurosci Lett (1994) 0.90
Comparison of the RNAs of murine and human coronaviruses. Adv Exp Med Biol (1981) 0.90
Conditioning as a critical determinant of sensitization induced by psychomotor stimulants. NIDA Res Monogr (1990) 0.90
Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study. Ann Oncol (2013) 0.90
CD4+ and CD8+ T cells are not major effectors of mouse hepatitis virus A59-induced demyelinating disease. J Neurovirol (1997) 0.90
MHV-A59 pathogenesis in mice. Adv Exp Med Biol (1984) 0.90
Further requirements for cleavage by the murine coronavirus 3C-like proteinase: identification of a cleavage site within ORF1b. Virology (1999) 0.89
Mouse hepatitis virus ORF 2a is expressed in the cytosol of infected mouse fibroblasts. Virology (1990) 0.89
Receptor specificity and receptor-induced conformational changes in mouse hepatitis virus spike glycoprotein. Adv Exp Med Biol (2001) 0.89
Sensitization, kindling, and anticonvulsants in mania. J Clin Psychiatry (1989) 0.88
Slate-gray pigmentation of sun-exposed skin induced by amiodarone. J Am Acad Dermatol (1984) 0.88
Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels? J Clin Epidemiol (1996) 0.88
Conditioned sensitization to the psychomotor stimulant cocaine. Ann N Y Acad Sci (1992) 0.88
Intracellular localization of polypeptides encoded in mouse hepatitis virus open reading frame 1A. Adv Exp Med Biol (1995) 0.87
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group. J Clin Endocrinol Metab (2000) 0.87
Upregulation of adenosine A1 receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine: a quantitative autoradiographic study. Epilepsia (1989) 0.87
Kindling versus quenching. Implications for the evolution and treatment of posttraumatic stress disorder. Ann N Y Acad Sci (1997) 0.86
Apoptosis of hippocampal neurons after amygdala kindled seizures. Brain Res Mol Brain Res (1998) 0.86
Neural plasticity and emotional memory. Dev Psychopathol (1998) 0.86
Intracerebral and subarachnoid hemorrhage following use of methamphetamine ("speed"). Int Surg (1970) 0.86